Arax Advisory Partners’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.3K Buy
453
+313
+224% +$25.7K ﹤0.01% 1806
2025
Q4
$12.8K Sell
140
-4,937
-97% -$473K ﹤0.01% 2349
2025
Q3
$481K Buy
5,077
+4,718
+1,314% +$444K 0.01% 917
2025
Q2
$37.6K Buy
359
+45
+14% +$4.27K ﹤0.01% 1371
2025
Q1
$27.7K Buy
314
+264
+528% +$27.1K ﹤0.01% 1163
2024
Q4
$4.8K Sell
50
-32
-39% -$2.98K ﹤0.01% 1756
2024
Q3
$6.71K Sell
82
-10
-11% -$772 ﹤0.01% 1578
2024
Q2
$7.93K Buy
92
+72
+360% +$5.82K ﹤0.01% 1382
2024
Q1
$1.63K Hold
20
﹤0.01% 1074
2023
Q4
$1.33K Sell
20
-15
-43% -$1.04K ﹤0.01% 1082
2023
Q3
$2.56K Buy
35
+12
+52% +$811 ﹤0.01% 975
2023
Q2
$1.45K Hold
23
﹤0.01% 1043
2023
Q1
$1.35K Buy
23
+3
+15% +$182 ﹤0.01% 1049
2022
Q4
$1.23K Hold
20
﹤0.01% 1027
2022
Q3
$1K Hold
20
﹤0.01% 1087
2022
Q2
$1K Hold
20
﹤0.01% 1054
2022
Q1
$1K Hold
20
﹤0.01% 1041
2021
Q4
$1K Buy
+20
New +$1.17K ﹤0.01% 1021

Other funds holding HQY

Arax Advisory Partners's HQY Position: Q1 2026 in Review

Arax Advisory Partners increased its HealthEquity (HQY) stake by 224% in Q1 2026, buying an estimated $25.7K and bringing the position to 453 shares worth $37.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

Arax Advisory Partners first reported a position in HQY in Q4 2021 and has held it in 18 quarters since. The position peaked at $481K in Q3 2025. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Arax Advisory Partners held 453 shares of HealthEquity worth $37.3K as of Q1 2026.
  • Arax Advisory Partners bought 313 HealthEquity shares in Q1 2026, an estimated $25.7K.
  • HealthEquity made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #1806 holding.
  • Arax Advisory Partners first reported a position in HealthEquity in Q4 2021 and has held it in 18 quarters since.
  • Arax Advisory Partners's HealthEquity position peaked at $481K in Q3 2025.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.